Leukemia, 0887-6924

Journal

51 - 60 out of 63Page size: 10
Sort by: Title

Publications

  1. Published

    The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome

    Keith Wheatley, 1 Jul 2011, In: Leukemia. 25, 7, p. 1122-1127 6 p.

    Research output: Contribution to journal › Article

  2. Published

    The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: Results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

    Robert Hills, Keith Wheatley, 1 Jan 2013, In: Leukemia. 27, 1, p. 75-81 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    The impact of SF3B1 mutations in CLL on the DNA-damage response

    Ceri Oldreive, Tatjana Stankovic, May 2015, In: Leukemia. 29, 5, p. 1133-42 10 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype

    Anetta Ptasinska, Salam Assi, Conny Bonifer & Jeffery Allan, Jan 2016, In: Leukemia. 30

    Research output: Contribution to journal › Article › peer-review

  5. Published

    The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukaemia

    Dickens Pratt, 8 Jun 2006, In: Leukemia. 20, p. 1460-1461 2 p.

    Research output: Contribution to journal › Letter

  6. E-pub ahead of print

    The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia

    Pamela Kearns, 20 Mar 2018, In: Leukemia. 10 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

    Keith Wheatley, Oct 2010, In: Leukemia. 24, 10, p. 1700-12 13 p.

    Research output: Contribution to journal › Article › peer-review

  8. E-pub ahead of print

    Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3

    Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, In: Leukemia.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.

    McNeill Hayden, Dickens Pratt, Nick Davies, Farhat Khanim, Mark Drayson & Christopher Bunce, 1 Feb 2009, In: Leukemia. 23, 2, p. 292-304 13 p.

    Research output: Contribution to journal › Article

  10. Published

    Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

    Keith Wheatley, Robert Hills, 1 Dec 2005, In: Leukemia. 19, p. 2130-2138 9 p.

    Research output: Contribution to journal › Article

Previous 12 3 4 5 6 7 Next